U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C11H21N3O5.2H2O
Molecular Weight 311.3321
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of LYSYLGLUTAMIC ACID DIHYDRATE

SMILES

O.O.NCCCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(O)=O

InChI

InChIKey=MINFJZILONFWCU-FOMWZSOGSA-N
InChI=1S/C11H21N3O5.2H2O/c12-6-2-1-3-7(13)10(17)14-8(11(18)19)4-5-9(15)16;;/h7-8H,1-6,12-13H2,(H,14,17)(H,15,16)(H,18,19);2*1H2/t7-,8-;;/m0../s1

HIDE SMILES / InChI

Molecular Formula C11H21N3O5
Molecular Weight 275.3015
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Molecular Formula H2O
Molecular Weight 18.0153
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
[Effect of vilon and epithalone on induction and growth of induced bladder neoplasms in rats].
2001
Effects of peptides on generation of reactive oxygen species in subcellular fractions of Drosophila melanogaster.
2001 Jul
Modulating and protective effects of thymic peptides in lymphoid tissue culture.
2001 Jul-Aug
Effect of the dipeptide vilon on activity of digestive enzyme in rats of various ages.
2001 Jun
Inhibitory effect of peptide vilon on the development of induced rat urinary bladder tumors in rats.
2001 Jun
Immunohistochemical and morphometric analysis of effects of vilon and epithalon on functional morphology of radiosensitive organs.
2001 Mar
[Characteristics of effect of ultralow doses of vilon in organotypic culture of spleens from rats of various ages].
2002
[Effect of Epitalon and Vilon treatment on mammary carcinogenesis in transgenic erbB-2/NEU mice].
2002
[Functional morphology of organotypic culture of spleens from rats of various ages exposed to vilon].
2002
[The effect of vilon on the thymus and spleen in a radiation model of premature aging].
2002
Effect of vilon and epithalon on activity of enzymes in epithelial and subepithelial layers in small intestine of old rats.
2002 Dec
Epithalon inhibits tumor growth and expression of HER-2/neu oncogene in breast tumors in transgenic mice characterized by accelerated aging.
2002 Feb
In vitro effect of short peptides on expression of interleukin-2 gene in splenocytes.
2002 Jun
Studies of the effects of Vilon and Epithalon on gene expression in mouse heart using DNA-microarray technology.
2002 Mar
Effects of short peptides on thymocyte blast transformation and signal transduction along the sphingomyelin pathway.
2002 May
Effect of Vilon and Epithalon on glucose and glycine absorption in various regions of small intestine in aged rats.
2002 May
[Effect of dipeptide vilon on emotional stress resistance in rats].
2002 Nov
Inhibitory effect of the peptide epitalon on the development of spontaneous mammary tumors in HER-2/neu transgenic mice.
2002 Sep 1
[Combined effect of vilon and cyclophosphane on tumor transplants and lymphoid tissue explants in mice and rats of various age].
2003
[Reciprocal relation of proliferative activity in central and peripheral zones of splenic organ culture exposed to vilon in rats of various ages].
2003
[The study of the role of the water medium in the mechanism of action of peptides in low and ultra low doses].
2003 May-Jun
[The study of peptide effect in the mechanisms of angiogenesis and forming of microenvironment of the tumors in old rats].
2004
Bioregulator Vilon-induced reactivation of chromatin in cultured lymphocytes from old people.
2004
Elucidation of the effect of brain cortex tetrapeptide Cortagen on gene expression in mouse heart by microarray.
2004 Feb-Apr
Expression of argyrophilic proteins in the nucleolar organizer regions of human thymocytes and thymic epitheliocytes under conditions of coculturing with vilon and epithalon peptides.
2004 Jun
[The effect of vilon (Lys-Glu) on 1.2-dimethylhydrazine-induced neoplasia].
2005
[Application of peptide bioregulator in complex treatment of elderly cancer patients].
2005
[Vilon effect on consequences of repeated radioactive and mercuric impact in small doses].
2005
Effect of peptide Vilon on the content of transforming growth factor-beta and permeability of microvessels during experimental chronic renal failure.
2005 Jan
[Effect of thymomimetic vilon on blood coagulation system and fibrinolisis in diabetes mellitus type 1 patients of different age].
2006
[Effect of vilon on neuroendocrine status and sexual function of old male rats].
2006
Interleukin-2 concentration in hypothalamic structures of rats receiving peptides during mild stress.
2006 Apr
Anti-aging peptide bioregulators induce reactivation of chromatin.
2006 Apr
[Effect of vilon on the immunity status and coagulation hemostasis in patients of different age with diabetes mellitus].
2007
[Parallel analysis of c-Fos protein and interleukin-2 expression in hypothalamic cells under different influence].
2007 Feb
Comparative analysis of the expression of c-Fos and interleukin-2 proteins in hypothalamus cells during various treatments.
2008 Mar
[The use of peptide bioregulators for cancer prevention: results of 35 years of research experience and perspectives].
2009
Patents
Substance Class Chemical
Created
by admin
on Sat Dec 16 04:41:35 GMT 2023
Edited
by admin
on Sat Dec 16 04:41:35 GMT 2023
Record UNII
832IRM2G6W
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
LYSYLGLUTAMIC ACID DIHYDRATE
Systematic Name English
LYS-GLU DIHYDRATE
Common Name English
LYSINE GLUTAMATE DIHYDRATE
Common Name English
VILON DIHYDRATE
Common Name English
Lysine glutamate dihydrate [WHO-DD]
Common Name English
L-LYSINE L-GLUTAMATE DIHYDRATE
Common Name English
Code System Code Type Description
EPA CompTox
DTXSID30241585
Created by admin on Sat Dec 16 04:41:35 GMT 2023 , Edited by admin on Sat Dec 16 04:41:35 GMT 2023
PRIMARY
CAS
94729-48-3
Created by admin on Sat Dec 16 04:41:35 GMT 2023 , Edited by admin on Sat Dec 16 04:41:35 GMT 2023
PRIMARY
PUBCHEM
71587354
Created by admin on Sat Dec 16 04:41:35 GMT 2023 , Edited by admin on Sat Dec 16 04:41:35 GMT 2023
PRIMARY
FDA UNII
832IRM2G6W
Created by admin on Sat Dec 16 04:41:35 GMT 2023 , Edited by admin on Sat Dec 16 04:41:35 GMT 2023
PRIMARY
EVMPD
SUB25762
Created by admin on Sat Dec 16 04:41:35 GMT 2023 , Edited by admin on Sat Dec 16 04:41:35 GMT 2023
PRIMARY
SMS_ID
100000089891
Created by admin on Sat Dec 16 04:41:35 GMT 2023 , Edited by admin on Sat Dec 16 04:41:35 GMT 2023
PRIMARY
Related Record Type Details
ANHYDROUS->SOLVATE
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY